by Qingyang Li | Mar 6, 2022 | CURE!
ARO-APOC3 is an investigational therapeutic being evaluated by Arrowhead Pharmaceuticals, Inc. forthe treatment of FCS. A Phase 3 clinical trial, the AROAPOC3-3001 Palisade Study is currently recruitingadults with a clinical diagnosis of FCS at multiple research...
by Qingyang Li | Dec 2, 2020 | FCS News
During the latest FCS patient-caregiver virtual meeting (link) hosted by the FCS Foundation, Ionis introduced the BALANCE study to the meeting attendance. Today, Ionis officially announced the initiation of the global Phase 3 BALANCE study via a press release (link)....
by Qingyang Li | Jul 19, 2020 | FCS News
CNN interviewed FCS Foundation’s co-presidents Melissa and Lindsey about the #TheHeartAct2020. It was an honor to share our journey with them. The FCS community is so proud to support this legislation and work alongside so many #raredisease groups, including the...
by Melissa | Sep 20, 2017 | Patient Stories
To My Younger Self After My Daughter’s Rare Disease Diagnosis Dear Melissa, Well, this isn’t what you were expecting. Your mind is racing, you feel numb and you’re in shock. It’s OK. It’s all OK. Because here’s the thing: You’re going to feel a lot of things over the...
by Nate | Feb 2, 2017 | Patient Stories
Throughout my childhood, I was a very active kid. I spent many days working on my grandfather’s dairy farm and enjoyed skiing and playing football, soccer and basketball. While to others I seemed like a normal relatively healthy boy, looking back I now can see that I...
by Lindsey | Jan 30, 2017 | Patient Stories
Dear FCS, “We sure have been through a lot together, and after 25 years, I am still trying to figure you out. You make my life so hard almost every single day. I cannot go an hour without stressing that, because of you, I am going to get pancreatitis. I worry every...
by Nate | Jan 29, 2017 | Patient Stories
Being a typical guy, I put off going to a doctor. But the pain eventually became so excruciating that I had to go to the hospital. According to medical resources, the high concentration of chylomicrons in plasma can lead to problems such as acute recurrent...
Recent Comments